Cancer cells often rely on NAD+ to fuel their rapid growth, but adequate NAD+ also supports DNA repair and anti-tumour immunity
BPC 157 effectively ameliorated ischemia/reperfusion injuries and as such is a possible new therapeutic solution in ischemic/reperfusion injuries
Momentum Peptides supplies research peptides UK-wide, with a commitment to 99% purity across our peptide range and uncompromising sourcing standards
For liver health, a Phase 2a trial in patients with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as NAFLD) showed extraordinary results
After drug intervention, all three treatment groups showed significantly lower expression levels of these inflammatory and fibrotic markers compared to the db/db group
The products are norepinephrine, dehydroascorbate, and H 2 O